SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6U7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	ALA B 690 THR B 739 CYH B 742 LEU B 777 HIS B 784	6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.5A) None None	0.55A	1uwhA-5kkrB: 18.7	1uwhA-5kkrB: 34.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 THR B 739 LEU B 777 HIS B 784	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) None None	0.48A	1uwjA-5kkrB: 10.1	1uwjA-5kkrB: 34.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	ILE B 672 VAL B 680 ALA B 690 THR B 739 CYH B 742 LEU B 777	6U7 B1001 ( 4.8A) 6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.5A) None	1.07A	1uwjB-5kkrB: 10.1	1uwjB-5kkrB: 34.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	ILE B 672 VAL B 680 ALA B 690 THR B 739 LEU B 777 HIS B 784	6U7 B1001 ( 4.8A) 6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) None None	0.87A	1uwjB-5kkrB: 10.1	1uwjB-5kkrB: 34.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	VAL B 680 ALA B 690 THR B 739 LEU B 741 THR B 802 PHE B 804	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-4.6A) 6U7 B1001 (-3.6A) 6U7 B1001 (-3.8A)	0.65A	3bbtB-5kkrB: 24.7	3bbtB-5kkrB: 27.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_D_MTXD164_2 (DIHYDROFOLATE REDUCTASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	3 / 3	ARG B 684 ILE B 738 THR B 802	None None 6U7 B1001 (-3.6A)	0.68A	3ia4D-5kkrB: undetectable	3ia4D-5kkrB: 22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	ILE B 672 VAL B 680 ALA B 690 THR B 739 CYH B 742 PHE B 804	6U7 B1001 ( 4.8A) 6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.5A) 6U7 B1001 (-3.8A)	1.01A	3og7A-5kkrB: 17.0	3og7A-5kkrB: 36.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	ILE B 672 VAL B 680 ALA B 690 THR B 739 PHE B 793	6U7 B1001 ( 4.8A) 6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-4.3A)	0.71A	3og7A-5kkrB: 17.0	3og7A-5kkrB: 36.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	4 / 8	VAL B 722 VAL B 723 ILE B 801 ASP B 803	None None None 6U7 B1001 (-4.6A)	0.61A	3wzeA-5kkrB: 19.6	3wzeA-5kkrB: 25.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 THR B 739 CYH B 742 PHE B 804	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.5A) 6U7 B1001 (-3.8A)	0.80A	4rzvB-5kkrB: 23.5	4rzvB-5kkrB: 36.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 THR B 739 CYH B 742 PHE B 793	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.5A) 6U7 B1001 (-4.3A)	0.78A	5cswA-5kkrB: 21.7	5cswA-5kkrB: 36.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 THR B 739 CYH B 742 PHE B 793	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.5A) 6U7 B1001 (-4.3A)	0.77A	5cswB-5kkrB: 26.0	5cswB-5kkrB: 36.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H2U_D_1N1D504_1 (PROTEIN-TYROSINE KINASE 6)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	VAL B 680 ALA B 690 ILE B 737 THR B 739 LEU B 741 ASP B 803	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 ( 4.1A) 6U7 B1001 (-4.0A) 6U7 B1001 (-4.6A) 6U7 B1001 (-4.6A)	0.63A	5h2uD-5kkrB: 22.3	5h2uD-5kkrB: 26.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HES_A_032A401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 ILE B 737 THR B 739 PHE B 804	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 ( 4.1A) 6U7 B1001 (-4.0A) 6U7 B1001 (-3.8A)	0.70A	5hesA-5kkrB: 9.1	5hesA-5kkrB: 28.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HIE_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 ILE B 737 THR B 739 PHE B 793	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 ( 4.1A) 6U7 B1001 (-4.0A) 6U7 B1001 (-4.3A)	0.54A	5hieA-5kkrB: 25.1	5hieA-5kkrB: 35.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HIE_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 ILE B 737 THR B 739 PHE B 793	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 ( 4.1A) 6U7 B1001 (-4.0A) 6U7 B1001 (-4.3A)	0.55A	5hieB-5kkrB: 25.2	5hieB-5kkrB: 35.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HIE_D_P06D801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 12	VAL B 680 ALA B 690 ILE B 737 THR B 739 PHE B 793	6U7 B1001 ( 4.3A) 6U7 B1001 (-3.6A) 6U7 B1001 ( 4.1A) 6U7 B1001 (-4.0A) 6U7 B1001 (-4.3A)	0.56A	5hieD-5kkrB: 25.0	5hieD-5kkrB: 35.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	GLU B 670 ILE B 672 GLY B 673 ALA B 690 CYH B 742 ASP B 803	None 6U7 B1001 ( 4.8A) None 6U7 B1001 (-3.6A) 6U7 B1001 (-3.5A) 6U7 B1001 (-4.6A)	0.65A	5vc3A-5kkrB: 20.5	5vc3A-5kkrB: 24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	6 / 12	GLU B 670 ILE B 672 GLY B 673 ALA B 690 PHE B 793 ASP B 803	None 6U7 B1001 ( 4.8A) None 6U7 B1001 (-3.6A) 6U7 B1001 (-4.3A) 6U7 B1001 (-4.6A)	0.99A	5vc3A-5kkrB: 20.5	5vc3A-5kkrB: 24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCV_A_1N1A404_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	4 / 5	VAL B 680 LEU B 741 CYH B 742 ASP B 803	6U7 B1001 ( 4.3A) 6U7 B1001 (-4.6A) 6U7 B1001 (-3.5A) 6U7 B1001 (-4.6A)	0.84A	5vcvA-5kkrB: 20.1	5vcvA-5kkrB: 26.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	4 / 4	VAL B 723 LEU B 741 ASN B 791 ASP B 803	None 6U7 B1001 (-4.6A) None 6U7 B1001 (-4.6A)	0.84A	5vcyA-5kkrB: 20.1	5vcyA-5kkrB: 26.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W5V_A_ANWA701_0 (SERINE/THREONINE-PRO TEIN KINASE TBK1)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	5 / 9	ALA B 690 VAL B 723 CYH B 742 GLY B 744 THR B 802	6U7 B1001 (-3.6A) None 6U7 B1001 (-3.5A) None 6U7 B1001 (-3.6A)	1.14A	5w5vA-5kkrB: 14.5	5w5vA-5kkrB: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_S_PCFS603_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	5kkr	KINASE SUPPRESSOR OF RAS 2 (Homo sapiens)	4 / 7	GLY B 744 PHE B 793 VAL B 799 SER B 749	None 6U7 B1001 (-4.3A) None None	0.81A	6hu9S-5kkrB: undetectable 6hu9q-5kkrB: undetectable	6hu9S-5kkrB: 16.39 6hu9q-5kkrB: 17.90

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UWH_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"ALA B 690;THR B 739;CYH B 742;LEU B 777;HIS B 784","6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-3.5A);None;None","0.55A","1uwhA-5kkrB:18.7",null],["1UWJ_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;THR B 739;LEU B 777;HIS B 784","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);None;None","0.48A","1uwjA-5kkrB:10.1","1uwhA-5kkrB:34.86"],["1UWJ_B_BAXB1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"ILE B 672;VAL B 680;ALA B 690;THR B 739;CYH B 742;LEU B 777","6U7 B1001 ( 4.8A);6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-3.5A);None","1.07A","1uwjB-5kkrB:10.1","1uwjA-5kkrB:34.86"],["1UWJ_B_BAXB1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"ILE B 672;VAL B 680;ALA B 690;THR B 739;LEU B 777;HIS B 784","6U7 B1001 ( 4.8A);6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);None;None","0.87A","1uwjB-5kkrB:10.1","1uwjB-5kkrB:34.86"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"VAL B 680;ALA B 690;THR B 739;LEU B 741;THR B 802;PHE B 804","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-4.6A);6U7 B1001 (-3.6A);6U7 B1001 (-3.8A)","0.65A","3bbtB-5kkrB:24.7","1uwjB-5kkrB:34.86"],["3IA4_D_MTXD164_2","DIHYDROFOLATE REDUCTASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",3,"ARG B 684;ILE B 738;THR B 802","None;None;6U7 B1001 (-3.6A)","0.68A","3ia4D-5kkrB:undetectable","3bbtB-5kkrB:27.87"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"ILE B 672;VAL B 680;ALA B 690;THR B 739;CYH B 742;PHE B 804","6U7 B1001 ( 4.8A);6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-3.5A);6U7 B1001 (-3.8A)","1.01A","3og7A-5kkrB:17.0","3ia4D-5kkrB:22.12"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"ILE B 672;VAL B 680;ALA B 690;THR B 739;PHE B 793","6U7 B1001 ( 4.8A);6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-4.3A)","0.71A","3og7A-5kkrB:17.0","3og7A-5kkrB:36.31"],["3WZE_A_BAXA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",4,"VAL B 722;VAL B 723;ILE B 801;ASP B 803","None;None;None;6U7 B1001 (-4.6A)","0.61A","3wzeA-5kkrB:19.6","3og7A-5kkrB:36.31"],["4RZV_B_032B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;THR B 739;CYH B 742;PHE B 804","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-3.5A);6U7 B1001 (-3.8A)","0.80A","4rzvB-5kkrB:23.5","3wzeA-5kkrB:25.88"],["5CSW_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;THR B 739;CYH B 742;PHE B 793","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-3.5A);6U7 B1001 (-4.3A)","0.78A","5cswA-5kkrB:21.7","4rzvB-5kkrB:36.91"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;THR B 739;CYH B 742;PHE B 793","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 (-4.0A);6U7 B1001 (-3.5A);6U7 B1001 (-4.3A)","0.77A","5cswB-5kkrB:26.0","5cswA-5kkrB:36.28"],["5H2U_D_1N1D504_1","PROTEIN-TYROSINE KINASE 6","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"VAL B 680;ALA B 690;ILE B 737;THR B 739;LEU B 741;ASP B 803","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 ( 4.1A);6U7 B1001 (-4.0A);6U7 B1001 (-4.6A);6U7 B1001 (-4.6A)","0.63A","5h2uD-5kkrB:22.3","5cswB-5kkrB:36.28"],["5HES_A_032A401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;ILE B 737;THR B 739;PHE B 804","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 ( 4.1A);6U7 B1001 (-4.0A);6U7 B1001 (-3.8A)","0.70A","5hesA-5kkrB:9.1","5h2uD-5kkrB:26.91"],["5HIE_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;ILE B 737;THR B 739;PHE B 793","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 ( 4.1A);6U7 B1001 (-4.0A);6U7 B1001 (-4.3A)","0.54A","5hieA-5kkrB:25.1","5hesA-5kkrB:28.45"],["5HIE_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;ILE B 737;THR B 739;PHE B 793","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 ( 4.1A);6U7 B1001 (-4.0A);6U7 B1001 (-4.3A)","0.55A","5hieB-5kkrB:25.2","5hieA-5kkrB:35.20"],["5HIE_D_P06D801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"VAL B 680;ALA B 690;ILE B 737;THR B 739;PHE B 793","6U7 B1001 ( 4.3A);6U7 B1001 (-3.6A);6U7 B1001 ( 4.1A);6U7 B1001 (-4.0A);6U7 B1001 (-4.3A)","0.56A","5hieD-5kkrB:25.0","5hieB-5kkrB:35.20"],["5VC3_A_DB8A601_1","WEE1-LIKE PROTEIN KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"GLU B 670;ILE B 672;GLY B 673;ALA B 690;CYH B 742;ASP B 803","None;6U7 B1001 ( 4.8A);None;6U7 B1001 (-3.6A);6U7 B1001 (-3.5A);6U7 B1001 (-4.6A)","0.65A","5vc3A-5kkrB:20.5","5hieD-5kkrB:35.20"],["5VC3_A_DB8A601_1","WEE1-LIKE PROTEIN KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",6,"GLU B 670;ILE B 672;GLY B 673;ALA B 690;PHE B 793;ASP B 803","None;6U7 B1001 ( 4.8A);None;6U7 B1001 (-3.6A);6U7 B1001 (-4.3A);6U7 B1001 (-4.6A)","0.99A","5vc3A-5kkrB:20.5","5vc3A-5kkrB:24.40"],["5VCV_A_1N1A404_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",4,"VAL B 680;LEU B 741;CYH B 742;ASP B 803","6U7 B1001 ( 4.3A);6U7 B1001 (-4.6A);6U7 B1001 (-3.5A);6U7 B1001 (-4.6A)","0.84A","5vcvA-5kkrB:20.1","5vc3A-5kkrB:24.40"],["5VCY_A_DB8A401_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",4,"VAL B 723;LEU B 741;ASN B 791;ASP B 803","None;6U7 B1001 (-4.6A);None;6U7 B1001 (-4.6A)","0.84A","5vcyA-5kkrB:20.1","5vcvA-5kkrB:26.30"],["5W5V_A_ANWA701_0","SERINE\/THREONINE-PROTEIN KINASE TBK1","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",5,"ALA B 690;VAL B 723;CYH B 742;GLY B 744;THR B 802","6U7 B1001 (-3.6A);None;6U7 B1001 (-3.5A);None;6U7 B1001 (-3.6A)","1.14A","5w5vA-5kkrB:14.5","5vcyA-5kkrB:26.30"],["6HU9_S_PCFS603_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","5kkr","KINASE SUPPRESSOR OF RAS 2","Homo sapiens",4,"GLY B 744;PHE B 793;VAL B 799;SER B 749","None;6U7 B1001 (-4.3A);None;None","0.81A","6hu9S-5kkrB:undetectable;6hu9q-5kkrB:undetectable","5w5vA-5kkrB:19.50"]]